Single Cancer Test Could Screen for Dozens of Diseases in Over-50s
News Context
At a glance
- the galleri test represents a significant step forward in cancer screening.
- The Galleri test analyzes blood samples for tiny fragments of tumor DNA, aiming to detect cancer at an early stage, even before symptoms manifest.
- The test is being evaluated on a large cohort of NHS patients aged 50-77, with results anticipated next year.
New Blood Test Detects 50 Types of Cancer
Table of Contents
Key Findings & Performance
The Galleri test analyzes blood samples for tiny fragments of tumor DNA, aiming to detect cancer at an early stage, even before symptoms manifest.
| Metric | Value |
|---|---|
| Cancer Detection Rate (in those with cancer) | 43% |
| Specificity (correctly ruling out cancer) | 99.5% |
| Accuracy in Pinpointing Cancer Origin | 88% |
| Comparison to Traditional Screening | Outperforms, with a higher rate of true positives (43% vs. 10%) |
The test is being evaluated on a large cohort of NHS patients aged 50-77, with results anticipated next year. Sir Harpal Kumar, former chief executive of Cancer Research UK, is involved with grail.
The goal is to potentially offer this test annually to individuals over 50 as a mass screening tool.